Legal Representation
Attorney
Ron N. Dreben
USPTO Deadlines
Application History
32 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 25, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jun 25, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jun 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 18, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Dec 18, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Dec 18, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 30, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 28, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jun 28, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jun 28, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 2, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 2, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jan 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 5, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 2, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jul 2, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 2, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 1, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Jul 1, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jul 1, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 1, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jan 4, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Nov 9, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 9, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 20, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 5, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 5, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 10, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 13, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical diagnostic blood testing apparatus for use in the field of coronary artery disease; Medical test kits in the field of coronary artery disease consisting primarily of a blood collection tube containing a preservative, a set of reagents for purifying RNA, a set of primers and probes for quantifying transcript levels, and related computer software featuring an algorithm for computing risk of coronary artery disease sold as a unit, for home use and for use by medical practitioners in the diagnosis of Atherosclerotic burden; medical devices for diagnosing coronary artery disease
Class 042
Research services in the field of medicine, namely, scientific research services and medical research
Class 044
Medical services, medical testing of blood, medical testing for diagnostic purposes, medical testing, namely, coronary artery disease (CAD) testing for diagnostic or treatment purposes, medical assessment services, namely, providing coronary and vascular risk assessment for diagnostic or treatment purposes, stroke risk assessment for diagnostic or treatment purposes, aneurysm risk assessment for diagnostic or treatment purposes, and peripheral vascular disease risk assessment for diagnostic or treatment purposes; providing medical advice, namely, providing Atherosclerotic load risk assessment guidance for hypercholesterolemia treatment purposes; medical testing in the nature of appendicitis testing by measuring RNA or protein levels in blood, pneumonia testing by measuring RNA or protein levels in blood, and biofilm testing by measuring RNA or protein levels in blood, all for diagnostic or treatment purposes; medical analysis for the treatment of coronary artery disease (CAD); healthcare
Classification
International Classes
010
042
044